Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) EBT Margin (2018 - 2025)

Historic EBT Margin for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to 22.05%.

  • Nexgel's EBT Margin rose 35900.0% to 22.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.91%, marking a year-over-year increase of 329400.0%. This contributed to the annual value of 39.86% for FY2024, which is 381100.0% up from last year.
  • According to the latest figures from Q3 2025, Nexgel's EBT Margin is 22.05%, which was up 35900.0% from 22.19% recorded in Q2 2025.
  • Over the past 5 years, Nexgel's EBT Margin peaked at 22.05% during Q3 2025, and registered a low of 463.64% during Q1 2022.
  • For the 5-year period, Nexgel's EBT Margin averaged around 135.22%, with its median value being 90.59% (2024).
  • Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 5028900bps in 2021, then tumbled by -1999700bps in 2022.
  • Quarter analysis of 5 years shows Nexgel's EBT Margin stood at 166.42% in 2021, then fell by -30bps to 216.02% in 2022, then soared by 49bps to 109.7% in 2023, then skyrocketed by 75bps to 27.1% in 2024, then grew by 19bps to 22.05% in 2025.
  • Its last three reported values are 22.05% in Q3 2025, 22.19% for Q2 2025, and 24.16% during Q1 2025.